Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Robert C. Petersen who wrote (519)	3/25/1998 7:43:00 AM
From: EmuGreg	Respond to of 4140

For me, the most interesting thing about the WSJ article was that it categorized the market for laser eye surgery (i.e., Lasik) as "surging." This is consistent with the projections of Lasik procedures that I have seen which reflect about a 50% growth rate per year. I have noticed a much greater awareness and acceptance of laser eye surgery in my circle of contacts in the past 2 years (probably thanks primarily to BEAM and VISX). This is one of the reasons that I believe that the ramp-up of patient procedures for SNRS will be much quicker than Summit and VISX experienced. Just some thoughts... Greg

To: Robert C. Petersen who wrote (519)	3/25/1998 9:34:00 AM
From: Nanny	Read Replies (1) \| Respond to of 4140

Bob, that press release yesterday could be huge for SNRS too! As you may well know, there are a lot of LASIK AND PRK patients who were over corrected and miserable. Hyperopes are unhappy patients and myopes are less unhappy. Well....what if you made a myope a hyperope by overcorrecting with the excimer? They are more unhappy than they were before the initial excimer procedure! Not only can they NOT see distance, but now they cannot read without their glasses as they could before. This news is really good for those unhappy overcorrected patients. How many are there? Lots? A few? Comments? Just wondering.......... Nanny